
Danielle Antalffy
Stock Analyst at UBS
(3.95)
# 1,860
Out of 5,184 analysts
604
Total ratings
50.9%
Success rate
3.6%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Rated: Buy | $95 → $107 | $79.32 | +34.90% | 41 | Oct 30, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $158 → $135 | $103.00 | +31.07% | 38 | Apr 20, 2026 | |
| BSX Boston Scientific | Rated: Buy | $120 → $105 | $41.98 | +150.12% | 42 | Mar 17, 2026 | |
| ISRG Intuitive Surgical | Rated: Hold | $570 → $550 | $399.05 | +37.83% | 10 | Mar 17, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $214 → $280 | $270.47 | +3.52% | 34 | Mar 17, 2026 | |
| SYK Stryker | Rated: Hold | $400 → $380 | $310.00 | +22.58% | 20 | Mar 17, 2026 | |
| SGHT Sight Sciences | Rated: Buy | $12 → $11 | $10.18 | +8.06% | 6 | Mar 6, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Buy | $62 → $30 | $24.70 | +21.46% | 9 | Mar 2, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Hold | $2.5 → $2.25 | $4.31 | -47.80% | 15 | Mar 2, 2026 | |
| RXST RxSight | Reiterated: Hold | $8 → $9 | $4.47 | +101.34% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $22 | $17.46 | +26.00% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $133.17 | +200.37% | 43 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $55 | $55.39 | -0.70% | 26 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.36 | +79.64% | 2 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $104 | $99.94 | +4.06% | 40 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $19 | $25.39 | -25.17% | 26 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $89 → $67 | $55.10 | +21.60% | 21 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 → $90 | $101.85 | -11.63% | 42 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $86 → $89 | $101.10 | -11.97% | 18 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $17.13 | +40.11% | 1 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $150 | $237.31 | -36.79% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $50 | $25.47 | +96.31% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $16 | $12.42 | n/a | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $2.25 | $5.40 | n/a | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $102.10 | n/a | 10 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $7.95 | n/a | 11 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $0.7716 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.46 | n/a | 5 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $275 | $212.78 | n/a | 6 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $55 | $2.81 | n/a | 10 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $55.75 | n/a | 6 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $57.52 | n/a | 14 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $5 | $4.16 | n/a | 14 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.30 | n/a | 20 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3 | $8.02 | n/a | 14 | Aug 9, 2021 |
DexCom
Oct 30, 2026
Rated: Buy
Price Target: $95 → $107
Current: $79.32
Upside: +34.90%
Abbott Laboratories
Apr 20, 2026
Reiterated: Buy
Price Target: $158 → $135
Current: $103.00
Upside: +31.07%
Boston Scientific
Mar 17, 2026
Rated: Buy
Price Target: $120 → $105
Current: $41.98
Upside: +150.12%
Intuitive Surgical
Mar 17, 2026
Rated: Hold
Price Target: $570 → $550
Current: $399.05
Upside: +37.83%
Johnson & Johnson
Mar 17, 2026
Rated: Buy
Price Target: $214 → $280
Current: $270.47
Upside: +3.52%
Stryker
Mar 17, 2026
Rated: Hold
Price Target: $400 → $380
Current: $310.00
Upside: +22.58%
Sight Sciences
Mar 6, 2026
Rated: Buy
Price Target: $12 → $11
Current: $10.18
Upside: +8.06%
PROCEPT BioRobotics
Mar 2, 2026
Reiterated: Buy
Price Target: $62 → $30
Current: $24.70
Upside: +21.46%
Treace Medical Concepts
Mar 2, 2026
Reiterated: Hold
Price Target: $2.5 → $2.25
Current: $4.31
Upside: -47.80%
RxSight
Feb 26, 2026
Reiterated: Hold
Price Target: $8 → $9
Current: $4.47
Upside: +101.34%
Feb 20, 2026
Reiterated: Hold
Price Target: $17 → $22
Current: $17.46
Upside: +26.00%
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $133.17
Upside: +200.37%
Feb 18, 2026
Reiterated: Buy
Price Target: $58 → $55
Current: $55.39
Upside: -0.70%
Feb 18, 2026
Reiterated: Buy
Price Target: $24
Current: $13.36
Upside: +79.64%
Feb 17, 2026
Reiterated: Hold
Price Target: $104
Current: $99.94
Upside: +4.06%
Feb 16, 2026
Reiterated: Hold
Price Target: $21 → $19
Current: $25.39
Upside: -25.17%
Feb 13, 2026
Reiterated: Hold
Price Target: $89 → $67
Current: $55.10
Upside: +21.60%
Feb 12, 2026
Reiterated: Hold
Price Target: $94 → $90
Current: $101.85
Upside: -11.63%
Feb 11, 2026
Reiterated: Sell
Price Target: $86 → $89
Current: $101.10
Upside: -11.97%
Feb 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $17.13
Upside: +40.11%
Jan 28, 2026
Reiterated: Buy
Price Target: $145 → $150
Current: $237.31
Upside: -36.79%
Jan 5, 2026
Reiterated: Buy
Price Target: $57 → $50
Current: $25.47
Upside: +96.31%
Nov 6, 2025
Reiterated: Hold
Price Target: $16 → $16
Current: $12.42
Upside: n/a
Mar 28, 2023
Initiated Coverage: Hold
Price Target: $2.25
Current: $5.40
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $100
Current: $102.10
Upside: n/a
May 12, 2022
Reiterated: Buy
Price Target: $12
Current: $7.95
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $13
Current: $0.7716
Upside: n/a
May 9, 2022
Reiterated: Buy
Price Target: $12
Current: $4.46
Upside: n/a
May 5, 2022
Rated: Hold
Price Target: $275
Current: $212.78
Upside: n/a
May 5, 2022
Rated: Buy
Price Target: $65 → $55
Current: $2.81
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $12 → $14
Current: $55.75
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $45
Current: $57.52
Upside: n/a
May 3, 2022
Rated: Buy
Price Target: $5
Current: $4.16
Upside: n/a
Jan 10, 2022
Reiterated: Hold
Price Target: n/a
Current: $5.30
Upside: n/a
Aug 9, 2021
Reiterated: Hold
Price Target: $2 → $3
Current: $8.02
Upside: n/a